PHEBRA POTASSIUM PHOSPHATE CONCENTRATED Injection

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

monobasic potassium phosphate, Quantity: 109.33 mg/mL; dibasic potassium phosphate, Quantity: 105.33 mg/mL

Mevcut itibaren:

Phebra Pty Ltd

Farmasötik formu:

Injection, intravenous infusion

Kompozisyon:

Excipient Ingredients: water for injections

Uygulama yolu:

Intravenous

Paketteki üniteler:

10mL x 10

Reçete türü:

Not scheduled. Not considered by committee

Terapötik endikasyonlar:

INDICATIONS AS AT 01 JANUARY 1991 : Treatment of severe hypophosphataemia (serum levels <0.3mmol/l) and other degrees of hypophosphataemia when oral therapy is not possible. Lowering the pH of urine. The treatment of potassium depletion in patients with hypokalemia. IV administration is indicated when the patient is unable to take potassium orally or if hypokalemia is severe.

Ürün özeti:

Visual Identification: Clear colourless solution; Container Type: Vial; Container Material: Glass; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Yetkilendirme durumu:

Registered

Yetkilendirme tarihi:

1991-10-14